Article
Performance comparison of four commercial human whole-exome capture platforms.
Scientific reports - 3 Aug 2015
Shigemizu Daichi, Momozawa Yukihide, Abe Testuo, Morizono Takashi, Boroevich Keith A, Takata Sadaaki, Ashikawa Kyota, Kubo Michiaki, Tsunoda Tatsuhiko
Abstract excerpt
Whole exome sequencing (WXS) is widely used to identify causative genetic mutations of diseases. However, not only have several commercial human exome capture platforms been developed, but substantial updates have been released in the past few years. We report a performance comparison for the latest release of four commercial platforms, Roche/NimbleGen's SeqCap EZ Human Exome Library v3.0, Illumina's Nextera...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
